Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Anemias”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03876821
What this trial is testing

Collect of Cord Blood From Subjects at Risk for Sickle Cell Disease, for the Purpose of Laboratory Research

Who this might be right for
Sickle Cell Disease
Institut National de la Santé Et de la Recherche Médicale, France 44
Not applicableEnded earlyNCT02619006
What this trial is testing

Infant Brain Study Follow-Up at 3 and 4 Years of Age

Who this might be right for
Iron DeficiencyChild Development
University of Rhode Island 10
Testing effectiveness (Phase 2)Study completedNCT03342404
What this trial is testing

Determine the Efficacy and Safety of Luspatercept in Adults With Non Transfusion Dependent Beta (β)-Thalassemia

Who this might be right for
Thalassemia
Celgene 145
Large-scale testing (Phase 3)Study completedNCT02720536
What this trial is testing

Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation

Who this might be right for
Chronic Iron Overload
Novartis Pharmaceuticals 53
Not applicableStudy completedNCT00723567
What this trial is testing

A Novel Mutation of the Spectrin Gene

Who this might be right for
Hereditary Elliptocytosis (HE)Hereditary Pyropoikilocytosis (HPP)
University of Utah 12
Testing effectiveness (Phase 2)Ended earlyNCT00034528
What this trial is testing

Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia

Who this might be right for
HemoglobinopathiesAnemia, Sickle CellHemoglobin SC Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 2
Post-approval studies (Phase 4)Ended earlyNCT02041299
What this trial is testing

Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias

Who this might be right for
Iron OverloadSickle Cell DiseaseOther Anemias
ApoPharma 230
Not applicableLooking for participantsNCT05799118
What this trial is testing

Study of the Role of Genetic Modifiers in Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseThalassemia, BetaThalassemia Alpha+1 more
Cyprus Institute of Neurology and Genetics 30,000
Not applicableUnknownNCT04205123
What this trial is testing

Biological, Genetic and Environmental Involved in the Complications of Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Erasme University Hospital 200
Early research (Phase 1)UnknownNCT02380079
What this trial is testing

Dose-Escalation Study of SCD-101 in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle-Beta Zero Thalassemia
Invenux, LLC 60
Testing effectiveness (Phase 2)Study completedNCT04987489
What this trial is testing

Etavopivat in Patients With Thalassemia or Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseThalassemia
Forma Therapeutics, Inc. 53
Not applicableStudy completedNCT00005891
What this trial is testing

Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Fanconi's Anemia

Who this might be right for
Fanconi's Anemia
Fairview University Medical Center
Large-scale testing (Phase 3)Ended earlyNCT05632354
What this trial is testing

GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD)

Who this might be right for
Sickle Cell Disease
Pfizer 47
Not applicableStudy completedNCT05791591
What this trial is testing

Safety and Efficacy of Orally Administered NUV001 Nutraceutical Supplement in Sickle Cell Disease Patients

Who this might be right for
Sickle Cell Disease
LGD 168
Testing effectiveness (Phase 2)Study completedNCT02993224
What this trial is testing

Open-label, Multicenter Study Assessing Preference for Deferasirox Film-coated Tablet Compared to Dispersible Tablet

Who this might be right for
Transfusion-dependent ThalassemiaNon-transfusion-dependent Thalassemia
Novartis Pharmaceuticals 148
Not applicableUnknownNCT04090268
What this trial is testing

Precision Exercise in Children With Malignant Hemopathies

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, B-cellLeukemia, T Cell+5 more
University of Milano Bicocca 380
Testing effectiveness (Phase 2)Ended earlyNCT04247594
What this trial is testing

Dose Escalation Study to Evaluate the Safety, Tolerability, PK and PD of Voxelotor in Patients With SCD

Who this might be right for
Sickle Cell Disease
Pfizer 6
Early research (Phase 1)Study completedNCT07023029
What this trial is testing

A Study on the Effect of Etavopivat on Heart Rhythm in Healthy Participants

Who this might be right for
Healthy VolunteersSickle Cell DiseaseThalassemia
Novo Nordisk A/S 33
Testing effectiveness (Phase 2)Looking for participantsNCT07023666
What this trial is testing

Early Screening and Treatment of Heart Complication in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Inova Health Care Services 100
Not applicableStudy completedNCT04081272
What this trial is testing

Effect of G6PD Deficiency on Red Blood Cell Storage

Who this might be right for
G6PD Deficiency
Columbia University 40
Next Page